Veeva selecteerde een van ‘s werelds beste industriële, technologische en technische innovators om ventilatoren voor het VK te leveren
BARCELONA, Spanje – (BUSINESS WIRE) – In een poging het tekort aan ventilatoren tijdens COVID-19 te helpen verhelpen, kondigde Veeva Systems (NYSE: VEEV) vandaag aan dat VentilatorChallengeUK Veeva Vault QMS gebruikte om de ventilatorproductie voor het VK te versnellen. Het consortium van de meest innovatieve bedrijven in het VK in de ruimtevaart-, auto- en medische sector helpen bij het voldoen aan de landelijke behoefte aan meer ventilatoren om COVID-19-patiënten te behandelen. Met Vault QMS automatiseerde VentilatorChallengeUK processen om de productie snel op te schalen en de kwaliteit te garanderen om meer dan 13.000 ventilatoren te leveren aan de National Health Service (NHS).
Veeva Vault Helps VentilatorChallengeUK Speed Production of More Than 13,000 Ventilators for COVID-19
Veeva selected among the world’s top industrial, technology, and engineering innovators to deliver ventilators for the UK
BARCELONA, Spain–(BUSINESS WIRE)– In an effort to help overcome the shortage of ventilators during COVID-19, Veeva Systems (NYSE: VEEV) today announced that VentilatorChallengeUK used Veeva Vault QMS to accelerate ventilator production for the U.K. The consortium of the U.K.’s most innovative companies across the aerospace, automotive, and medical industries is helping meet the nationwide need for more ventilators to treat COVID-19 patients. With Vault QMS, VentilatorChallengeUK automated processes to rapidly scale production and ensure quality to deliver more than 13,000 ventilators to the National Health Service (NHS).
“Veeva allowed us to streamline quality across all of our manufacturing sites to get ventilators to the patients that need them faster,” said Dick Elsy, chairman of VentilatorChallengeUK and CEO of the High Value Manufacturing Catapult. “The speed of the Veeva team was critical to helping us produce such a large volume of devices in under three months.”
Ventilator production was already underway when VentilatorChallengeUK transitioned from paper and manual processes to Veeva’s modern, cloud-based quality management system. Vault QMS was ready for production in 10 days across multiple manufacturing facilities. With improved control and visibility into quality processes, the consortium tripled its number of ventilators in just four weeks. Partners were able to quickly ramp up production and maintain better quality throughout the end-to-end supply chain.
“We’re proud to support VentilatorChallengeUK and achieve their goal of getting important medical equipment to patients,” said Chris Moore, president of Veeva in Europe. “Thank you to the consortium and Veeva employees for their incredible teamwork to help treat U.K. citizens with COVID-19.”
VentilatorChallengeUK includes 33 companies that have come together to manufacture and deliver ventilators, including Airbus, Ford, Penlon, Siemens Healthineers, and STI. For more information on VentilatorChallengeUK and its members, visit ventilatorchallengeuk.com.
Learn more about Veeva Vault QMS at the upcoming Veeva R&D and Quality Summit, October 13-14, 2020. The virtual event is only open to life sciences industry professionals. Register and stay up-to-date on program details at veeva.com/R&DSummit. Also, watch the on-demand presentations from Veeva R&D and Quality Summit, Europe at veeva.com/EUSummit.
For more information on Veeva Vault QMS, visit veeva.com/VaultQMS
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About the VentilatorChallengeUK
The consortium consists of significant UK industrial, technology, and engineering businesses from across the aerospace, automotive and medical sectors, that have come together to produce medical ventilators for the UK. The VentilatorChallengeUK consortium is committed to playing its role in delivering both medical ventilator designs to the required specifications and, in conjunction with these other companies, organizations and groups, aid the delivery of additional ventilators to the NHS.
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 875 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.